Merck to discontinue development of Covid-19 drug MK-7110
Kenilworth, New Jersey (dpa/AFX) – Merck (MRK) said on Thursday that it has decided to discontinue development of MK-7110, formerly known as CD24Fc, for the treatment of hospitalized patients with COVID-19, after the US Food and Drug Administration asked the company to provide additional data to support a potential Emergency Use Authorization application. Merck acquired…
US weekly jobless claims tumble much more than expected
Washington (dpa/AFX) – A report released by the Labor Department on Thursday showed first-time claims for US unemployment benefits pulled back by much more than anticipated in the week ended April 10. The Labor Department said initial jobless claims tumbled to 576,000, a decrease of 193,000 from the previous week’s revised level of 769,000. Economists…
